鉻（三價鉻） Chromium × 第二型糖尿病
結論：證據分歧
整體證據呈「薄弱證據（C 級）」：L2 PubMed 文獻顯示鉻補充對既存第二型糖尿病的 HbA1c 效益高度異質——Anderson 1997 中國族群（n=180）大幅 -1.
C 🟠 C 薄弱證據 證據分歧 ⚠️ medium — moderate promotional content
整體證據呈「薄弱證據（C 級）」：L2 PubMed 文獻顯示鉻補充對既存第二型糖尿病的 HbA1c 效益高度異質——Anderson 1997 中國族群（n=180）大幅 -1.9% 為極端 outlier（疑反映基線缺乏），Suksomboon 2014 MA（25 RCT）僅 -0.55%，Kleefstra 2007 西方族群陰性，Yin 2015 MA 對 chromium picolinate 之 HbA1c 無顯著效應，Costello 2016 NIH ODS 系統回顧明確指出僅 3/14 試驗達臨床意義門檻；所有試驗皆為 surrogate biomarker（無 incidence/mortality/CV event 等硬性臨床終點）。
L5e ADA Standards of Care 2026 §5.16 明文點名鉻為「證據不足以支持常規使用」，EASD/DNSG 2023 全文未提及鉻；L5c Cleveland Clinic 註冊營養師明確建議避免、L5d Harvard 引述 ADA 立場不背書、L5a NIH ODS 與 L5b Mayo 偏 cautious。
L1 Examine 給 HbA1c 為 B（Moderate Improvement）但僅基於 9 RCT n=468 的 surrogate 平均，未權衡 ADA 的不推薦立場，亦不能涵蓋人群異質性與形式差異（picolinate vs yeast vs brewer's yeast 結果不同）。
獨立判讀為 C：機轉合理、有少量正向訊號、但學會主流不推薦、效果幅度多在臨床無意義範圍。
⚖️
評分透明度
所有分數由 7 層證據引擎計算，過程公開可查原始分數 0.43
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
C · 證據分歧
信心度
70%
證據方向大致一致
證據層級
E2
多篇高品質統合分析（≥2 篇一致）
▸查看完整決策路徑（audit trail）
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.427
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 高品質 SR/MA 顯示 positive (1 篇 > 0 negative)
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 1 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes
結論：Chinese cohort: HbA1c fell from 8.5% (placebo) to 6.6% in 1000 mcg/day group at 4 months; fasting and 2-h insulin decreased in both chromium groups; plasma cholesterol improved in high-dose group. Large effect not replicated in Western populations.
前往 PubMed
Chromium treatment has no effect in patients with type 2 diabetes in a Western population: a randomized, double-blind, placebo-controlled trial
結論：No significant difference in HbA1c between chromium and placebo; no effect on lipids, BMI, blood pressure, or insulin requirements. Authors conclude chromium yeast is not effective for glycemic control in Western T2DM patients on OHAs.
前往 PubMed
Systematic review and meta-analysis of the efficacy and safety of chromium supplementation in diabetes
結論：25 RCTs. HbA1c MD -0.55% (95% CI -0.88 to -0.22, p=0.001) and FPG MD -1.15 mmol/L (95% CI -1.84 to -0.47, p=0.001) favoring chromium; chromium picolinate and doses >200 mcg/day drove the effect. Heterogeneity acknowledged; safety comparable to placebo at usual doses.
前往 PubMed
Chromium supplements for glycemic control in type 2 diabetes: limited evidence of effectiveness
結論：Only 3/14 trials reaching HbA1c <=7% and 5/14 with >=0.5% HbA1c decline. Authors (NIH ODS) conclude chromium supplements have limited effectiveness and there is little rationale to recommend them for glycemic control in existing T2DM — consistent with ADA Standards of Care, which do not recommend chromium.
前往 PubMed
Effect of chromium supplementation on glycated hemoglobin and fasting plasma glucose in patients with diabetes mellitus
結論：No statistically significant effect on HbA1c for chromium yeast, brewer's yeast, or chromium picolinate. Only brewer's yeast showed FPG reduction (MD -19.23 mg/dL) vs placebo. Authors conclude chromium offers at most marginal FPG benefit and no HbA1c benefit.
前往 PubMed
L4a US FDA
謹慎
One small study suggests that chromium picolinate may reduce the risk of insulin resistance, and therefore possibly may reduce the risk of type 2 diabetes. FDA concludes, however, that the existence of such a relationship between chromium picolinate and either insulin resistance or type 2 diabetes is highly uncertain. 來源↗
L4b EU EFSA
反對
The Panel concludes that there is no evidence of beneficial effects associated with chromium intake in healthy subjects ... no Average Requirement (AR) and Population Reference Intake (PRI) can be defined; chromium is not an essential nutrient. 來源↗
L4c UK NHS
謹慎
You should be able to get all the chromium you need by eating a varied and balanced diet. Around 25 micrograms of chromium a day should be enough for adults. Having 10mg or less a day of chromium from food and supplements is unlikely to cause any harm. 來源↗
L4d TW TFDA / 衛福部
支持
每日食用量中，其鉻之總含量不得高於200微克 來源↗
L4e WHO
未表態
Chromium[VI] is carcinogenic to humans (Group 1). Metallic chromium and chromium[III] compounds are not classifiable as to their carcinogenicity to humans (Group 3). 來源↗
L5a NIH Office of Dietary Supplements
謹慎
Research suggests that chromium supplementation reduces body weight and body fat percentage to a very small, but statistically significant, extent. However, these effects have little clinical significance. 來源↗
L5b Mayo Clinic
謹慎
There is evidence that shows chromium can decrease fasting blood glucose, insulin levels, and hemoglobin A1C (HbA1C), and can increase insulin sensitivity in people with type 2 diabetes. 來源↗
L5c Cleveland Clinic
謹慎
I'd advise a lot of caution with using chromium supplements. There is a risk of interactions with some medications and potential negative side effects — and not enough evidence that there's an upside. 來源↗
L5d Harvard Health
謹慎
L5e Specialty Society (condition-mapped)
反對
There is insufficient evidence to support the routine use of herbal supplements and micronutrients, such as cinnamon, curcumin (e.g., turmeric), aloe vera, or chromium, to improve glycemia in people with type 1 or type 2 diabetes. 來源↗
PTT · Dcard · Mobile01 彙整自公開論壇討論，非統計抽樣，僅反映社群風向。
廣告 / 業配密度 中度
低中高
📍立場總覽
台灣社群討論鉻（三價鉻）用於第二型糖尿病的真實心得屬中等量，且幾乎都集中在『含鉻配方的糖尿病營養品』脈絡，而非單方鉻補充劑。PTT elderly/Health/regimen 版多在問『長輩糖尿病推薦營養品』時推桂格完膳鉻100/鉻50、力增鉻100、愛斯康鉻100、亞培等配方奶，鄉民實測多回報『血糖保持得還不錯、醫生檢查時稱讚』但屬個別經驗。社群共識是『飲食控制＋運動＋藥物才是不二法門，鉻配方只是輔助、不能取代正規治療』。單方吡啶甲酸鉻（chromium picolinate）的討論偏減肥/抑制食慾與抗氧化脈絡，糖尿病框架較弱。PTT 業配密度低、以親身經驗為主；商業健康媒體與痞客邦則較多廠商置入。
💬社群實感
分歧偏中性（含鉻糖尿病配方營養品如鉻100有零星正面心得『血糖保持得不錯』，但多與飲食運動藥物併行、難歸功於鉻本身；社群普遍視為輔助而非療效來源，單方鉻補充劑控糖心得稀少）
破解迷思 社群最常見的 5 個誤解
✓
事實把保健用『三價鉻』與工業致癌的『六價鉻』混為一談，誤以為補鉻=吃重金屬（實際三價鉻無毒、吸收率低，六價鉻才是人為汙染物）
✓
事實誤以為補鉻或喝『鉻100』配方能直接降血糖、治療糖尿病（鉻僅輔助胰島素敏感性，不能取代降血糖藥與飲食控制）
✓
事實對『鉻100』數字期望過高，以為含量越高越能控糖（仍須搭配整體飲食生活習慣，且每日上限約 200 微克）
✓
事實誤以為各種鉻補充品吸收率相同（無機鉻吸收率僅約 1–2%，有機的吡啶甲酸鉻可達 10–25%，差距達十倍）
✓
事實把吡啶甲酸鉻的『減肥/抑制食慾』口碑直接套到『降血糖治糖尿病』，混淆兩種使用脈絡
🩹 社群通報的副作用
- 高劑量（600–1000 微克）噁心、腹瀉（多引自媒體/說明，非鄉民實測）
- 頭痛、失眠（高劑量補充劑脈絡）
- 與降血糖藥/胰島素併用時的低血糖風險（社群提醒須監測）
- 減肥食品鉻過量中毒疑慮（自由時報報導脈絡，非糖尿病使用心得）
🏷️ 社群熱議品牌
依論壇被提及頻率，非銷售或品質排序。
- 桂格完膳糖尿病配方（鉻50 / 鉻100，PTT 最常被推、品項多）
- 力增鉻100系列（友華）
- 愛斯康鉻100（友華生技，被讚口味清甜好喝）
- 亞培（安素/葡勝納/金補體素等糖尿病配方營養品）
- iHerb 各家吡啶甲酸鉻 Chromium Picolinate（單方補充劑，偏減重/血糖脈絡）
⚠️ 列出僅代表「TW 社群討論度高」，不代表本站推薦或背書。本站不販售任何產品、無導購連結。
- 醫療營養治療與減重
- 規律身體活動
- Metformin（二甲雙胍）
查看 ClaimReview 結構化資料 (JSON-LD)
{
"@context": "https://schema.org",
"@type": "ClaimReview",
"url": "https://gpt-dict.com/claim/CLM-COND-type2-diabetes-INT-chromium-001/",
"datePublished": "2026-06-01",
"author": {
"@type": "Organization",
"name": "gpt-dict.com",
"url": "https://gpt-dict.com"
},
"claimReviewed": "鉻（三價鉻）能改善第二型糖尿病",
"inLanguage": "zh-TW",
"itemReviewed": {
"@type": "Claim",
"appearance": []
},
"reviewRating": {
"@type": "Rating",
"ratingValue": 2,
"bestRating": 5,
"worstRating": 1,
"alternateName": "🟠 C 薄弱證據"
}
}